Autolus Therapeutics (AUTL) Net Cash Flow (2017 - 2025)
Autolus Therapeutics posted quarterly Net Cash Flow of $17.4 million for Q4 2025, up 104.45% year-on-year from $8.5 million in Q4 2024, and up 151.05% on a QoQ basis from -$34.1 million in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Net Cash Flow data on file, last reported at $17.4 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 104.45% year-over-year to $17.4 million; the trailing twelve-month figure through Dec 2025 stood at -$129.4 million (down 1048.72% YoY), and the FY2025 full-year result was -$129.4 million, down 1048.72% from the prior year.
- Net Cash Flow for Q4 2025 stood at $17.4 million, up from -$34.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $520.4 million in Q1 2024 and bottomed at -$391.5 million in Q4 2024.
- The 5-year median for Net Cash Flow is -$35.0 million (2022), against an average of -$2.0 million.
- Peak annual rise in Net Cash Flow reached 1213.57% in 2024, while the deepest fall reached 1389.39% in 2024.
- A 5-year view of Net Cash Flow shows it stood at $136.7 million in 2021, then jumped by 52.42% to $208.3 million in 2022, then sank by 112.62% to -$26.3 million in 2023, then sank by 1389.39% to -$391.5 million in 2024, then surged by 104.45% to $17.4 million in 2025.
- The last three Net Cash Flow figures came in at $17.4 million (Q4 2025), -$34.1 million (Q3 2025), and $22.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -152.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 17.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.42 Mn |
| Dec 31, 2025 | 17.42 Mn |
| Sep 30, 2025 | -34.13 Mn |
| Sep 30, 2025 | -34.13 Mn |
| Jun 30, 2025 | 22.37 Mn |
| Jun 30, 2025 | 22.37 Mn |
| Mar 31, 2025 | -135.11 Mn |
| Mar 31, 2025 | -135.11 Mn |
| Dec 31, 2024 | -391.52 Mn |
| Dec 31, 2024 | -391.52 Mn |
| Sep 30, 2024 | -86.14 Mn |
| Sep 30, 2024 | -86.14 Mn |
| Jun 30, 2024 | -54.00 Mn |
| Jun 30, 2024 | -54.00 Mn |
| Mar 31, 2024 | 520.39 Mn |
| Mar 31, 2024 | 520.39 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Sep 30, 2023 | -41.68 Mn |
| Sep 30, 2023 | -41.68 Mn |
| Jun 30, 2023 | -42.76 Mn |
| Jun 30, 2023 | -42.76 Mn |
| Mar 31, 2023 | -46.73 Mn |
| Mar 31, 2023 | -46.73 Mn |
| Dec 31, 2022 | 208.31 Mn |
| Dec 31, 2022 | 208.31 Mn |
| Sep 30, 2022 | -38.60 Mn |
| Sep 30, 2022 | -38.60 Mn |
| Jun 30, 2022 | -33.45 Mn |
| Jun 30, 2022 | -33.45 Mn |
| Mar 31, 2022 | -35.80 Mn |
| Mar 31, 2022 | -35.80 Mn |
| Dec 31, 2021 | 136.67 Mn |
| Dec 31, 2021 | 136.67 Mn |
| Sep 30, 2021 | -38.84 Mn |
| Sep 30, 2021 | -38.84 Mn |
| Jun 30, 2021 | -24.57 Mn |
| Jun 30, 2021 | -24.57 Mn |
| Mar 31, 2021 | 84.08 Mn |
| Mar 31, 2021 | 84.08 Mn |
| Dec 31, 2020 | -32.81 Mn |
| Dec 31, 2020 | -32.81 Mn |
| Sep 30, 2020 | -43.10 Mn |
| Sep 30, 2020 | -43.10 Mn |
| Jun 30, 2020 | -29.75 Mn |
| Jun 30, 2020 | -29.75 Mn |
| Mar 31, 2020 | 47.64 Mn |
| Mar 31, 2020 | 47.64 Mn |
| Jun 30, 2019 | 52.70 Mn |
| Jun 30, 2019 | 52.70 Mn |
| Mar 31, 2019 | -33.84 Mn |
| Mar 31, 2019 | -33.84 Mn |
| Sep 30, 2018 | -41.07 Mn |
| Sep 30, 2018 | -41.07 Mn |
| Jun 30, 2018 | 139.82 Mn |
| Jun 30, 2018 | 139.82 Mn |
| Mar 31, 2018 | -13.09 Mn |
| Mar 31, 2018 | -13.09 Mn |
| Dec 31, 2017 | -9.13 Mn |
| Dec 31, 2017 | -9.13 Mn |